Variability Analysis of the Vi-CELL BLU Cell Viability Analyzer against 3 Automated Cell Counting Devices and the Manual Method
In bioprocess monitoring—including antibody and virus production—the traditional manual cell counting method using a hemocytometer introduces significant, error-prone steps. Subjective operator differentiation, mixing inconsistencies, and strict time constraints often limit statistical confidence and introduce high variability. This technical application note presents a rigorous variability analysis evaluating the Vi-CELL BLU Cell Viability Analyzer against three alternative automated devices and the manual method.
Using three major suspension cell lines (CHO KI, HEK Expi293, and Sf9 ExpiSf9) cultured across up to 9 days, a comprehensive 2,240-data-point matrix was evaluated across a 10% to 100% dilution series. The Vi-CELL BLU system utilizes an automated trypan blue mixing and delivery mechanism to capture up to 100 high-resolution images in under 130 seconds. The statistical analysis, executed via JMP 16, focused on the Coefficient of Variation (%CV) for Total Cell Count (TCD), Viable Cell Density (VCD), and Viability percentage.
The results demonstrate that the Vi-CELL BLU analyzer achieves significantly lower replicate %CV across all cell lines compared to manual methods and alternative automated counters. By minimizing instrument-to-instrument and replicate variability, the Vi-CELL BLU system eliminates the need for excessive replicate testing, reduces operational costs, and provides bioprocess engineers with the reliable, consistent data required for critical, site-to-site process decisions.
Instrument Comparison
- Vi-CELL BLU: 2–60 $\mu$M diameter range, 5E+04 to 1.5E+07 density range, 200 $\mu$L sample volume, <130 sec analysis time (Fully Automated Prep & Counting).
- Manual Method: Highly variable analysis time, 10 $\mu$L sample volume, prone to subjective operator bias and high data spread.
Key Data Findings
- Reduced Variability: The Vi-CELL BLU demonstrated the lowest Mean %CV for TCD, VCD, and Viability across all tested days.
- High-Throughput Efficiency: High replicate reproducibility allows laboratories to confidently run single or minimal replicates, freeing up system capacity for alternative samples.
- Cross-Site Standardization: Proven low instrument-to-instrument variability establishes the platform as a reliable standard for multi-site bioprocess monitoring.
White Paper from 